RFX1 and hepatocellular carcinoma: In esophageal squamous and hepatocellular carcinomas, SNHG17 can promote EMT by targeting miR-338-3p/SOX4 and miR-3180-3p/regulatory factor X-box 1 (RFX1) axes, respectively (62, 63).